Our Company
Our Company
About us
Our Team
Technology
Pipeline
Intranasal Foralumab
Secondary Progressive Multiple Sclerosis
Alzheimer’s Disease
Other Indications
Anti IL-6R (TZLS-501)
Milciclib (TZLS-201)
Investors, News & Media
News
Media
Publications
Investors
Contact
Select Page
Jane King interviews Matthew Davis, M.D., Chief Medical Officer, Tiziana Life Sciences
23rd June 2023